HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Shively Selected Research

John Shively Research Topics

Disease

7Neoplasms (Cancer)
12/2023 - 04/2009
3Multiple Myeloma
01/2021 - 01/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 03/2017
1Stomach Neoplasms (Stomach Cancer)
12/2023
1Breast Neoplasms (Breast Cancer)
12/2023
1Cytopenia
02/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2018
1Ascites
01/2018
1Neoplasm Metastasis (Metastasis)
09/2017
1Mucositis
09/2017
1Colorectal Neoplasms (Colorectal Cancer)
09/2017
1Prostatic Neoplasms (Prostate Cancer)
04/2009

Drug/Important Bio-Agent (IBA)

3daratumumabIBA
01/2021 - 01/2018
3GemcitabineFDA Link
02/2020 - 03/2017
3AntigensIBA
01/2018 - 04/2009
2Carcinoembryonic AntigenIBA
02/2020 - 01/2019
2Glycoproteins (Glycoprotein)IBA
01/2018 - 04/2009
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
12/2023
1Trastuzumab (Herceptin)FDA Link
12/2023
1human ERBB2 proteinIBA
12/2023
1Biomarkers (Surrogate Marker)IBA
12/2023
1Indium-111IBA
02/2020
1Yttrium-90IBA
02/2020
1Coloring Agents (Dyes)IBA
01/2019
1AntibodiesIBA
01/2019
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2018
1Chimeric Antigen ReceptorsIBA
01/2018
1CytokinesIBA
01/2018
1CopperIBA
01/2018
1Floxuridine (FUdR)FDA LinkGeneric
09/2017
1Nucleotide AptamersIBA
03/2017
1Cytotoxins (Cytolysins)IBA
03/2017
1Histones (Histone)IBA
03/2017
1NucleosidesIBA
03/2017
1LigandsIBA
04/2009

Therapy/Procedure

6Therapeutics
12/2023 - 09/2017
2Radioimmunotherapy
09/2017 - 04/2009
1Immunotherapy
12/2023